Caribou Biosciences, Inc. (CRBU)
1.62
+0.07
(+4.52%)
USD |
NASDAQ |
Feb 18, 16:00
1.62
0.00 (0.00%)
After-Hours: 17:34
Caribou Biosciences Total Liabilities (Quarterly) : 53.14M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| SELLAS Life Sciences Group, Inc. | 5.925M |
| GT Biopharma, Inc. | 1.321M |
| Aclaris Therapeutics, Inc. | 55.43M |
| Nurix Therapeutics, Inc. | 163.82M |
| Lyell Immunopharma, Inc. | 78.84M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 194.98M |
| Shareholders Equity (Quarterly) | 141.84M |
| Debt to Equity Ratio | 0.1795 |
| Current Ratio | 5.542 |
| Net Debt Paydown Yield | 0.17% |